People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Biotechnology, Other Health Care, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Reshape Medical, Inc. | — | Biotechnology | Series B | $75.1M | $436.6M | 2012 |
| Spinal Kinetics Inc | — | Other Health Care | Series B | $53.7M | $28.4M | 2009 |
| Aquesys Inc | — | Biotechnology | Series B | $49.5M | $1.2B | 2014 |
| Altura Medical, Inc. | — | Other Health Care | Series A | $27.0M | $121.1M | 2010 |
| MindFrame Inc. | — | Other Health Care | Series A | $23.0M | $131.2M | 2010 |
| Sadra Medical, Inc. | — | Other Health Care | Series B | $23.0M | $88.6M | 2009 |
| Tixologi, Inc. | — | Other | Seed | $3.1M | $4.7M | 2023 |
David Milne at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Milne on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bruce Feuchter | 3 | 12 |
| George Wallace | 3 | 8 |
| Jeani Delagardelle | 2 | 8 |
| Andrew Cragg | 2 | 5 |
| David A. Milne | 2 | 2 |
| Richard Thompson | 1 | 17 |
| Richard Ferrari | 1 | 15 |
| FARHAD KHOSRAVI | 1 | 14 |
| Casey Tansey | 1 | 14 |
| Robert Grant | 1 | 12 |
| Michael Carusi | 1 | 7 |
| Ryan Schwarz | 1 | 7 |
| Charles Larsen | 1 | 7 |
| Anthony Lando | 1 | 6 |
| Jeffrey Lightcap | 1 | 5 |
| Juliet Tammenoms Bakker | 1 | 5 |
| Howard Lindzon | 1 | 5 |
| Mark Brooks | 1 | 5 |
| JAMES ADOX | 1 | 5 |
| Al Wiegman | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.